Cargando…

Exploring the potential of eRNAs in cancer immunotherapy

Detalles Bibliográficos
Autores principales: Luo, Lianxiang, Chen, Xinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647423/
https://www.ncbi.nlm.nih.gov/pubmed/36381659
http://dx.doi.org/10.1016/j.omto.2022.10.009
_version_ 1784827379033571328
author Luo, Lianxiang
Chen, Xinming
author_facet Luo, Lianxiang
Chen, Xinming
author_sort Luo, Lianxiang
collection PubMed
description
format Online
Article
Text
id pubmed-9647423
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-96474232022-11-14 Exploring the potential of eRNAs in cancer immunotherapy Luo, Lianxiang Chen, Xinming Mol Ther Oncolytics Editorial American Society of Gene & Cell Therapy 2022-11-08 /pmc/articles/PMC9647423/ /pubmed/36381659 http://dx.doi.org/10.1016/j.omto.2022.10.009 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Luo, Lianxiang
Chen, Xinming
Exploring the potential of eRNAs in cancer immunotherapy
title Exploring the potential of eRNAs in cancer immunotherapy
title_full Exploring the potential of eRNAs in cancer immunotherapy
title_fullStr Exploring the potential of eRNAs in cancer immunotherapy
title_full_unstemmed Exploring the potential of eRNAs in cancer immunotherapy
title_short Exploring the potential of eRNAs in cancer immunotherapy
title_sort exploring the potential of ernas in cancer immunotherapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647423/
https://www.ncbi.nlm.nih.gov/pubmed/36381659
http://dx.doi.org/10.1016/j.omto.2022.10.009
work_keys_str_mv AT luolianxiang exploringthepotentialofernasincancerimmunotherapy
AT chenxinming exploringthepotentialofernasincancerimmunotherapy